Safe dose of oxytocin to control excessive bleeding from uterus during cesarean section in patients with body weight above normal

Not Applicable

• Conditions: Health Condition 1: O754- Other complications of obstetric surgery and procedures

• Registration Number: CTRI/2022/05/042469
• Lead Sponsor: CMS and GTBH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 February 2023

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All non-laboring parturient >18 years age will be enrolled. The two arms will include obese (body mass index >=30 kg/m2) or non-obese pregnant patients (body mass index < 30 kg/m2) posted for cesarean section under spinal anesthesia.

Exclusion Criteria

Exclusion criteria shall be patient refusal, presence of labor (defined as cervical dilatation of 3 cm or more), use of oxytocin in the preoperative period, history of PPH or more than one previous uterine surgery as well as bleeding disorders, presence of abnormal placentation and uterine fibroid, contraindications to spinal block, such as hemodynamic instability, infection at the injection site, and coagulopathy (thrombocytopenia with platelet count <100,000/mm3 or INR >1.5).

Study & Design

• Study Type: Interventional
• Study Design: Not specified